Neurocognitive Indicators of Clinical High-Risk States for Psychosis: A Critical Review of the Evidence

Abstract

The present review investigates the empirical evidence from cross-sectional and long-term follow-up studies on neurocognitive indicators of an increased risk for developing schizophrenia spectrum psychoses in clinically defined high-risk samples. First, the investigations at the Cologne center for early recognition and intervention are briefly summarized and then integrated within the available literature. Thirty-two studies with original data could be identified by extensive literature search. Cross-sectional investigations of neurocognitive baseline assessments in high-risk samples with unknown conversion status have produced rather inconsistent results. Nevertheless, most convincing evidence could be collected for abnormal functioning in processing speed measures (digit symbol coding, Trailmaking Test-B, Stroop Color Naming), the Continuous Performance Test, verbal working memory measures, verbal memory and learning, and verbal fluency, though negative findings have also been reported in every instance. Moreover, high-risk subjects were found to perform both at the schizophrenia performance level and at a close to normal level. Longitudinal follow-up assessments provided predictive evidence with regard to psychosis conversion for measures of processing speed and of verbal memory and learning. However, a substantial number of negative findings does not allow for straight-forward conclusions. Finally, some reasons for inconsistent findings are discussed critically speculating on demographic differences, reliability and sample sizes, and conceptual imprecision in communicating results.

Ego Disturbances in the Sense of Kurt Schneider: Historical and Phenomenological Aspects

“…The aim of differentiating the depersonalization experience in the transitional area between psychosis and nonpsychosis is to more clearly determine differential diagnostic boundaries and to deliver new impulses for expanding the limits of early diagnostics [98,99]. An expectation which was formulated by Andreasen [100] in connection with the continued development of psychopathology has thus been met: ‘Fortunately, the Europeans still have a proud tradition of clinical research and descriptive psychopathology.…”

Neuroimaging and neuropsychological findings in pediatric obsessive–compulsive disorder: a review and developmental considerations

“…Pennington and Ozonoff point to a discriminant validity problem common to many neuropsychological tests, whereby symptomatically different behavioral disorders present with similar neuropsychological deficits [100]. For example, executive function impairments were found in nearly every anxiety disorder [153], as well as in eating disorders [154], bipolar disorder [155], major depressive disorder [156], post-traumatic stress disorder [89], schizophrenia [157], antisocial personality disorder [158] and borderline personality disorder [159].…”

Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders: Facilitation of Prognosis and Treatment

“…Chan et al (2009) observed some associations between some sustained attention assessment and schizotypal traits but no significant relationship between this assessment and clinical symptoms in patients with schizophrenia in this study; observations critical to the requirements of clinical staging in psychosis. Pukrop and Klosterkötter (2010) examined the risk situation for developing schizophrenia spectrum psychoses, of clinically defined high-risk subjects within an ''At Risk Mental State'' (ARMS). These patients were identified by the Cologne Early Recognition and Intervention Center, with regard to genetic, epidemiologic, and clinical high-risk studies on first-episode and multiple episode patients.…”